IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL5.67▼ 0.02% USD/MXN18.60▲ 0.46% USD/CLP994.16▼ 0.13% USD/COP 3,303 — 0.00% USD/PEN3.41▲ 0.13% USD/ARS1,544▼ 0.02% USD/UYU 40.59 — 0.00% USD/PYG 6,196 — 0.00% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC 442.74 — 0.00% USD/GTQ 7.64 — 0.00% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES911.74▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69— 0.00% USD/TTD6.75▲ 2.58% EUR/BRL6.25▼ 0.04% BRENT 96.25 ▲ 0.43% WTI 89.11 ▲ 0.62% IRON ORE 161.91 — — COPPER 6.03 ▼ 0.90% GOLD 3,856 ▼ 0.77% SILVER 47.33 ▼ 3.48% SOY 1,226 ▼ 1.39% CORN 444.25 ▼ 0.28% WHEAT 589.00 ▼ 0.72% COFFEE 279.25 ▼ 0.34% SUGAR 18.40 ▲ 0.99% ORANGE JUICE 136.85 ▼ 2.91% COTTON 78.68 ▲ 0.01% COCOA 5,123 ▲ 1.13% BEEF 224.80 ▲ 2.70% CATTLE 335.35 ▼ 0.10% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00% IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL 5.67 ▼ 0.02% USD/MXN 18.59 ▲ 0.43% USD/CLP 994.16 ▼ 0.13% USD/COP 3,303 — 0.00% USD/PEN 3.41 ▲ 0.09% USD/ARS 1,544 ▼ 0.02% USD/UYU 40.59 — 0.00% USD/PYG 6,196 — 0.00% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC 442.74 — 0.00% USD/GTQ 7.64 — 0.00% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES 911.74 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 2.75% USD/TTD 6.75 ▲ 2.58% EUR/BRL 6.25 ▼ 0.04% BRENT 96.25 ▲ 0.43% WTI 89.11 ▲ 0.62% IRON ORE 161.91 — — COPPER 6.03 ▼ 0.90% GOLD 3,856 ▼ 0.77% SILVER 47.33 ▼ 3.48% SOY 1,226 ▼ 1.39% CORN 444.25 ▼ 0.28% WHEAT 589.00 ▼ 0.72% COFFEE 279.25 ▼ 0.34% SUGAR 18.40 ▲ 0.99% ORANGE JUICE 136.85 ▼ 2.91% COTTON 78.68 ▲ 0.01% COCOA 5,123 ▲ 1.13% BEEF 224.80 ▲ 2.70% CATTLE 335.35 ▼ 0.10% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00%
since 2009
Monday, November 16, 2026

Game-changing synthetic antibiotics offer hope against superbugs

By · · 2 min read

RIO DE JANEIRO, BRAZIL – A group of scientists at the University of Liverpool (United Kingdom) has made a significant advance in research involving so-called synthetic antibiotics.

This new class of drugs is a beacon of hope in the fight against “superbugs” that are highly resistant to conventional antibiotics.

Read also: Check out our coverage on curated alternative narratives

Free daily brief — no card needed
Get every Crypto story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

In 2019, upwards of 1.2 million individuals perished from drug-resistant illnesses. But all of that could change with the advent of the ‘game-changing’ antibiotic that could potentially save millions, according to a new study.

In a groundbreaking research effort, British researchers have developed synthetic versions of a molecule called theixobactin, which some bacteria use to kill others. The synthesized version of this molecule had higher efficacy and safety and allowed for a grander scale and lower cost.

British researchers have developed synthetic versions of a molecule called theixobactin.
British researchers have developed synthetic versions of a molecule called theixobactin.
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

Teixobactin was first hailed as a “game-changing” antibiotic in 2015, but the new project has developed “synthetic” classes of the drug, scientists say.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Exxon gets Guyana approval for a gas project”

BROAD-SPECTRUM OF BACTERIA AFFECTED

The most important result of the research was the demonstration that synthetic antibiotics based on theixobactins were able to kill a broad spectrum of bacteria originating from human patients. The drugs even effectively fought the dreaded MSRA in mice.

MSRA is methicillin-resistant Staphylococcus Aureus, a bacterium in the Staphylococcus family that is highly resistant to conventional antibiotics. In tests on animal models, the synthetic antibiotics accumulated in more significant amounts than required to kill superbugs.

These data suggest that patients could be treated with just one daily dose of a synthetic antibiotic to treat life-threatening super bacterial infections in the future. In addition, synthetic theixobactins do not require a cold chain to be stored and distributed.

 

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

Read More from The Rio Times

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.